Advanced Search

 

Study ID Status Title Patient Level Data
110142 Completed Non-inferiority of co-administration of GSK Biologicals’pneumococcal conjugate vaccine GSK1024850A with DTPa-IPV-Hib versus co-administration with DTPa-HBV-IPV/Hib. Study Listed on ClinicalStudyDataRequest.com
110159 Completed A randomised, double-blind, placebo-controlled, 3-period crossover study to assess the efficacy and safety of single dose intranasal GSK1004723 compared with placebo in an allergen challenge chamber in male subjects with seasonal allergic rhinitis Study Listed on ClinicalStudyDataRequest.com
110163 Completed A randomised, double-blind, placebo-controlled, 4-period incomplete block crossover study of single oral dose GSK835726 (100mg, 50mg, 10mg), Cetirizine (10mg) and placebo to evaluate the efficacy and safety using an Environmental challenge chamber in male subjects with seasonal allergic rhinitis Study Listed on ClinicalStudyDataRequest.com
110168 Completed Evaluation of the immunogenicity and safety of GlaxoSmithKline Biologicals' HPV vaccine 580299 when administered as a 3-dose schedule in healthy Japanese pre-adolescent and adolescent female subjects. Study Listed on ClinicalStudyDataRequest.com
110215 Completed Immunogenicity & safety study in preterm & full-term infants of GSK Biologicals' Hib-MenC vaccine, Menitorix™ co-administered with Infanrix™ penta & Prevenar™ at 2, 4, 6 months & as a booster with Infanrix™ IPV & Prevenar™ at 16-18 months Study Listed on ClinicalStudyDataRequest.com
110215 Completed Immunogenicity & safety study in preterm & full-term infants of GSK Biologicals' Hib-MenC vaccine, Menitorix™ co-administered with Infanrix™ penta & Prevenar™ at 2, 4, 6 months & as a booster with Infanrix™ IPV & Prevenar™ at 16-18 months Study Listed on ClinicalStudyDataRequest.com
110221 Completed A Phase III study for evaluation of immunogenicity and reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in people aged 18 years or above Study Listed on ClinicalStudyDataRequest.com
110223 Completed Reactogenicity and immunogenicity of GSK Biologicals' influenza vaccine GSK576389A in elderly adults (≥67 years) previously vaccinated with the same candidate vaccine. Fluarix™ will be used as reference. Study Listed on ClinicalStudyDataRequest.com
110263 Completed Reactogenicity and immunogenicity of GSK Biologicals' influenza vaccine GSK576389A in elderly adults (≥66 years) previously vaccinated with the same candidate vaccine. Fluarix™ will be used as reference Study Listed on ClinicalStudyDataRequest.com
110264 Completed A Phase II Clinical Trial of Four Cycles of Doxorubicin and Cyclophosphamide Followed by Weekly Paclitaxel Given Concurrently with Pazopanib as Neoadjuvant Therapy Followed by Postoperative Pazopanib for Women with Locally Advanced Breast Cancer
110269 Completed An open label positron emission tomography study in healthy male subjects to investigate brain Dopamine D3 receptor occupancy, pharmacokinetics and safety of single oral doses of GSK618334, using 11C-PHNO as PET ligand. Study Listed on ClinicalStudyDataRequest.com
110341 Completed A randomised, double-blind, placebo-controlled, 4-period, incomplete block, crossover study to assess the dose-response curve of intranasal fluticasone propionate (25, 50, 100 and 200 g, once daily for 8 days) in the Vienna Challenge Chamber for the purpose of investigating the sensitivity of the model when evaluating glucocorticosteroids Study Listed on ClinicalStudyDataRequest.com
110399 Completed A Randomized, Double Blind, Parallel Group, Placebo Controlled 28 Day Study to Investigate the Safety, Tolerability and Pharmacodynamics of SB-656933 in Patients with Cystic Fibrosis. Study Listed on ClinicalStudyDataRequest.com
110464 Completed A trial to evaluate the safety and immunogenicity of an investigational vaccination regimen in adults aged ≥18 years Study Listed on ClinicalStudyDataRequest.com
110474 Completed An open, phase IV, single-group, multicentre study to assess the long-term persistence of antibodies against hepatitis B and the immune response to a hepatitis B (HBV) vaccine challenge in children aged 7-8 years of age and previously vaccinated in infancy with GSK Biologicals’ HBV vaccine (Engerix™-B). Study Listed on ClinicalStudyDataRequest.com
110478 Completed Immunogenicity and reactogenicity study of a new formulation of GSK Biologicals' DTPa-HBV-IPV/Hib vaccine administered as a booster dose to 18-23 months old children Study Listed on ClinicalStudyDataRequest.com
110502 Completed A Phase III, Open-Label, Single-Dose Study to Evaluate the Safety and Immunogenicity of Fluviral® Trivalent Split Virion Influenza Vaccine (2007 – 2008 Season) in Adults Ranging in Age from 18 to 60 Years and 61 Years and Over Study Listed on ClinicalStudyDataRequest.com
110521 Completed Primary vaccination course in children receiving the pneumococcal vaccine GSK 1024850A co-administered with Zilbrix™ Hib and Polio Sabin™ Study Listed on ClinicalStudyDataRequest.com
110584 Completed Immunogenicity and safety study of a single injection of GSK Biologicals' Trivalent Split virion Influenza vaccine Fluviral® (2008 - 2009 Season) in adults aged 18 to 60 years and over 60 years. Study Listed on ClinicalStudyDataRequest.com
110586 Completed Immunogenicity and safety study of GSK Biologicals’ Trivalent Split Virion Influenza Vaccine Fluviral® (2009 - 2010 Season) in adults aged 18 to 60 years and over 60 years. Study Listed on ClinicalStudyDataRequest.com
110620 Completed Non-Inferiority of GlaxoSmithKline Biologicals' Influenza Vaccine (GSK576389A) 1 Container Over 2 Container Presentation in Adults Aged 65 Years and Over Study Listed on ClinicalStudyDataRequest.com
110624 Completed A trial to evaluate the safety and immunogenicity of monovalent H5N1 vaccine in adults >=18 yrs of age Study Listed on ClinicalStudyDataRequest.com
110628 Completed Immunogenicity and safety study of GSK Biologicals’ (GSK1536489A) Trivalent Split Virion Influenza Vaccine Fluviral® (2010 - 2011 Season) in adults aged 18 to 60 years and over 60 years. Study Listed on ClinicalStudyDataRequest.com
110635 Terminated A double-blind, randomized, placebo controlled, parallel group, multi-center, phase III trial of ofatumumab investigating clinical efficacy in adult patients with active rheumatoid arthritis who have had an inadequate response to methotrexate therapy
110651 Completed A randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of the H3 receptor antagonist, GSK239512 in subjects with mild to moderate Alzheimer’s disease. Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.